Yfat Kadan

Tel Aviv University

H指数:11

被引数:454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project

口服抗凝剂可降低接受一线治疗的卵巢癌患者的静脉血栓栓塞症发生率——一项质量改进项目

Gynecologic Oncology

IF4.1

2026-08-060

PRE

Opportunistic Salpingectomy In Non-Gynecological Surgeries-A Pilot Study

机会性输卵管切除术在非妇科手术中的应用——一项试点研究

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

IF4.7

2025-02-010

PRE

DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer (vol 501, pg 224, 2021)

CANCER LETTERS

IF10.1

2023-06-010

OAAI

Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2022-10-234

PRE

Bahar-Shany, Keren; Barnabas, Georgina D.; Deutsch, Lisa; Deutsch, Netanel; Glick-Saar, Efrat; Dominissini, Dan; Sapoznik, Stav; Helpman, Limor; Perri, Tamar; Blecher, Anna; Katz, Guy; Yagel, Itai; Rosenblatt, Orgad; Shai, Daniel; Brandt, Benny; Meyer, Raanan; Mohr-Sasson, Aya; Volodarsky-Perel, Alexander; Zilberman, Itamar; Armon, Shunit; Jakobson-Setton, Ariella; Eitan, Ram; Kadan, Yfat; Beiner, Mario; Josephy, Dana; Brodsky, Malka; Friedman, Eitan; Anafi, Liat; Molchanov, Yossef; Korach, Jacob; Geiger, Tamar; Levanon, Keren

DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer

CANCER LETTERS

IF10.1

2021-03-0112

PREAI

Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

IF3.1

2020-10-3017

OAAI

The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions

ONCOGENESIS